SCM

Stonepine Capital Management Portfolio holdings

AUM $102M
This Quarter Return
-9.94%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$218M
AUM Growth
+$218M
Cap. Flow
+$15.8M
Cap. Flow %
7.24%
Top 10 Hldgs %
83.54%
Holding
39
New
8
Increased
13
Reduced
2
Closed
16

Top Buys

1
XERS icon
Xeris Biopharma Holdings
XERS
$16.6M
2
ADMA icon
ADMA Biologics
ADMA
$14M
3
CFMS
Conformis, Inc. Common Stock
CFMS
$10.9M
4
EOLS icon
Evolus
EOLS
$10.2M
5
ATRS
Antares Pharma, Inc.
ATRS
$7.26M

Top Sells

1
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
$19.2M
2
GLPG icon
Galapagos
GLPG
$12.8M
3
GYRE icon
Gyre Therapeutics
GYRE
$10.8M
4
SBBP
Strongbridge Biopharma plc.
SBBP
$9.16M
5
AFMD
Affimed
AFMD
$7.18M

Sector Composition

1 Healthcare 94.84%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ADMS
26
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
– –
-3,914,938
Closed -$19.2M
SPNE
27
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
– –
-8,349
Closed -$131K
GMDA
28
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
– –
-1,724,201
Closed -$6.76M
GLPG icon
29
Galapagos
GLPG
$2.06B
– –
-244,205
Closed -$12.8M
AFMD
30
DELISTED
Affimed
AFMD
– –
-1,161,466
Closed -$7.18M
ELTX icon
31
Elicio Therapeutics
ELTX
$169M
– –
-280,183
Closed -$2.74M
EYPT icon
32
EyePoint Pharmaceuticals
EYPT
$827M
– –
-80,537
Closed -$839K
GYRE icon
33
Gyre Therapeutics
GYRE
$734M
– –
-2,635,014
Closed -$10.8M
IMUX icon
34
Immunic
IMUX
$79.4M
– –
-22,409
Closed -$198K
KALV icon
35
KalVista Pharmaceuticals
KALV
$713M
– –
-200,000
Closed -$3.49M
LPTX icon
36
Leap Therapeutics
LPTX
$12M
– –
-250,000
Closed -$1M
SCYX icon
37
SCYNEXIS
SCYX
$35.2M
– –
-6,327
Closed -$34K
KA
38
DELISTED
Kineta, Inc. Common Stock
KA
– –
-481,692
Closed -$4.97M
NBSE
39
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
– –
-109,742
Closed -$396K
1
2